AdvaMed® Statement on President’s Reciprocal Tariff Pause
WASHINGTON – Today AdvaMed, the MedTech Association®, released the following statement from President and CEO Scott Whitaker:
Government & Legislative Affairs
Learn more about our Advocacy work.
AdvaMed®, Nine Other Organizations Urge Tariff Exemption for Medical Products
Washington, D.C.– AdvaMed, The Medtech Association®, and nine additional organizations urged an exemption from tariffs for medical and dental supplies, equipment, and devices, citing concerns about increased costs resulting in supply…
AdvaMed® Congratulates Dr. Oz on his Confirmation as CMS Administrator
Washington, D.C.– AdvaMed, The Medtech Association®, today released the following statement from President and CEO Scott Whitaker on the U.S. Senate’s confirmation of Dr. Mehmet Oz to serve as Administrator of…
AdvaMed® Statement on Today’s Tariff Announcement
Washington, D.C.– AdvaMed, the MedTech Association®, released the following statement from President and CEO Scott Whitaker: “Our country is the birthplace of the medical device and technology industry and leads the…
AdvaMed®’s Medical Innovation Agenda for the 119th Congress
AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Emerging Policy & Tariff Response Center
Get expert insights, key documents, and event details on trade and policy shifts.
AdvaMed® Congratulates Dr. Makary on his Confirmation as FDA Commissioner
Washington, D.C.– AdvaMed, The Medtech Association®, today released the following statement from President and CEO Scott Whitaker on the U.S. Senate’s confirmation of Dr. Marty Makary to serve as commissioner of…
AI Policy Roadmap
Discover how AI is transforming medical technology with the AI Policy Roadmap. Learn how Congress can unleash even more innovation with targeted legislation. Download your copy today!
The Medical Innovation Agenda for the 119th Congress
AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
AdvaMed® 2025 State Policy Briefing: EPR
Hear from Multistate policy experts Joe Rinzel and Townsend Brown as they discuss state product stewardship and producer responsibility policy trends.